AarXiv7 Oct 2025

Deciphering the Role of Acetate in Metabolic Adaptation and Osimertinib Resistance in Non-Small Cell Lung Cancer

Giorgia Maroni, Eva Cabrera San Millan, Beatrice Campanella, Massimo Onor, Giovanni Cercignani, Beatrice Muscatello, Giulia Braccini, Raffaella Mercatelli, Alice Chiodi, Ettore Mosca, Elena Levantini, Emilia Bramanti

Abstract

- (1) CNR-Consiglio Nazionale delle Ricerche, Istituto di Tecnologie Biomediche (ITB-CNR), SS di Pisa, Area della Ricerca di Pisa, Italy - (2) CNR-Consiglio Nazionale delle Ricerche, Istituto di Chimica dei Composti OrganoMetallici (ICCOM-CNR), SS di Pisa, Area della Ricerca di Pisa, Italy - (3) Scuola Normale di Pisa, Class of Sciences, Pisa, Italy - (4) Dipartimento di Farmacia, Università di Pisa, Pisa, Italy; Centro per l'Integrazione della Strumentazione dell'Università di Pisa (CISUP), Pisa, Italy

A figure from Deciphering the Role of Acetate in Metabolic Adaptation and Osimertinib Resistance in Non-Small Cell Lung Cancer — fig. from the paper

§ The Valyu brief

The paper, in five minutes

Read from the full text via Valyu Contents

Osimertinib‑resistant lung cancer cells reroute metabolism to a pyruvate‑acetaldehyde‑acetate shunt, raising acetate and NADPH production.

What’s new

i.Identified elevated acetate levels as a hallmark of osimertinib‑resistant NSCLC cells.
ii.Discovered activation of an unconventional pyruvate‑acetaldehyde‑acetate (PAA) shunt mediated by ALDH2 and ALDH7A1.
iii.Demonstrated that the PAA shunt supplies NADPH, supporting biosynthesis and redox balance under pentose phosphate pathway inhibition.
iv.Provided systematic transcriptomic and exometabolomic profiling that distinguishes resistant from parental cells and reveals therapeutic targets.

How they did it

The study combined integrated transcriptomic, exometabolomic, and functional analyses to compare osimertinib‑resistant cells with drug‑sensitive parental cells. Systematic metabolite profiling was performed to map changes in glycolysis, the pentose phosphate pathway, and the TCA cycle.

What they found

Resistant cells show significantly higher intracellular acetate concentrations.
ALDH2 and ALDH7A1 expression are up‑regulated, enabling NADP⁺‑dependent oxidation of acetaldehyde to acetate.
The PAA shunt generates NADPH, compensating for inhibited oxidative pentose phosphate pathway activity.
Metabolic reprogramming provides a de novo bypass for anaplerosis and bioenergetics in resistant cells.

§ The Valyu brief

Reading the full paper and taking notes. This takes a few seconds…

§ Ask this paper

Ask a question about this paper

Valyu reads the full text and answers from what the paper actually says.

§ Related work in other archives

Similar papers in all four archives

The same idea searched in arXiv, PubMed, bioRxiv and chemRxiv at once, so a method can lead you to where it is being applied.

AarXiv3 found

PPubMed4 found

BbioRxiv4 found

CchemRxiv2 found

Searching the other archives…